{"nctId":"NCT00236977","briefTitle":"Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia","startDateStruct":{"date":"2003-08"},"conditions":["Anemia"],"count":182,"armGroups":[{"label":"Venofer","type":"EXPERIMENTAL","interventionNames":["Drug: Venofer"]},{"label":"Ferrous Sulfate","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Ferrous Sulfate"]}],"interventions":[{"name":"Venofer","otherNames":["iron sucrose tablets"]},{"name":"Ferrous Sulfate","otherNames":["Oral Iron Tablets"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Hemoglobin \\< or = 11.5 gm/dL\n* Stable dose or not receiving EPO\n* Renal Anemia\n\nExclusion Criteria:\n\n* IV iron with last 6 months\n* Chronic infection, malignancy,major surgery within last month\n* Blood Transfusion with last two months\n* Significant blood loss within last 3 months\n* Concomitant sever diseases of the liver","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Patients With an Increase in Hemoglobin >= 1gm/dL.","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35","spread":null},{"groupId":"OG001","value":"23","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With a Clinical Response","description":"Clinical Response (change in Hemoblobin (Hgb) \\>= 1gm/dL and change in ferritin \\>= 160ng/ml)","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Highest Change From Baseline in Hemoglobin (g/dL) up to Day 56","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":".94"},{"groupId":"OG001","value":".8","spread":".78"}]}]}]},{"type":"SECONDARY","title":"Highest Change From Baseline in Ferritin (ng/mL) up to Day 56","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"391.7","spread":"213.19"},{"groupId":"OG001","value":"45","spread":"52.19"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Ferritin (ng/mL) From Baseline to Day 56","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"230","spread":"138.2"},{"groupId":"OG001","value":"30","spread":"54.63"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Serum Transferrin Saturation (TSAT) (%) at Day 56","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.5","spread":"8.31"},{"groupId":"OG001","value":"5.5","spread":"9.14"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Hemoglobin (g/dL) at Day 56","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":".7","spread":".94"},{"groupId":"OG001","value":".3","spread":".90"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":10,"n":91},"commonTop":["Constipation","Diarrhea NOS","Nausea","Oedema NOS","Fatigue"]}}}